Press Release - Company Data

Helix BioPharma Corp. Appoints New Independent Chair of the Board
Posted 2014-07-21 00:11NAI Editing
a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the appointment of Mr.

Helix BioPharma Corp. Initiates Enrollment for Ninth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47
Posted 2014-07-15 00:02NAI Editing
a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the opening of patient screening for the ninth dose level cohort in its o

Helix BioPharma Corp. Announces Completion of Private Placement
Posted 2014-07-11 00:04NAI Editing
a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has completed a private placement with net proceeds in excess of CAD5.4

Helix BioPharma Corp. Announces the Receipt of Subscription Agreements for a Net CAD5.4 Million Private Placement
Posted 2014-07-07 00:14NAI Editing
a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has received private placement subscription agreements for common share

Helix BioPharma Corp. Announces Fiscal Q3 2014 Results
Posted 2014-06-11 23:43NAI Editing
a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced financial results for the three and nine-month periods ended April 30, 2014 and 2013.

Helix BioPharma Corp. Receives U.S. Food and Drug Administration Approval to Initiate a Clinical Trial of L-DOS47 in Combination With Pemetrexed and Carboplatin
Posted 2014-04-21 23:36NAI Editing
a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has received approval from the U.S.

Helix BioPharma Corp. Announces Fiscal Q2 2014 Results
Posted 2014-03-14 02:35NAI Editing
a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced financial results for the three and six-month periods ended January 31, 2014 and 2013

Director of Helix BioPharma Corp. Acquires a Further 1,000,000 Common Shares
Posted 2014-01-10 00:23NAI Editing
a biopharmaceutical company dedicated to developing drugs for prevention and treatment of cancer, today announced that it has been advised by Dr.

Helix BioPharma Announces Director Resignation
Posted 2013-12-17 00:11NAI Editing
a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced that Mario Gobbo has resigned from Helix's board of directors.

Helix BioPharma Corp. Completes Data Review of First Four Cohorts of Its Phase I/II Clinical Study for Lung Cancer Drug Candidate L-DOS47
Posted 2013-10-14 23:30NAI Editing
a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has completed its interim review of the Company's ongoing Phase I/II c